US2004063183A1PendingUtilityA1

Process for producing d-mannitol

Priority: Dec 20, 2000Filed: Dec 19, 2001Published: Apr 1, 2004
Est. expiryDec 20, 2020(expired)· nominal 20-yr term from priority
C12P 7/18
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

High concentration of free cells of heterofermentative lactic acid bacteria (LAB) in a resting or slowly growing state are used to convert fructose into mannitol. Efficient volumetric mannitol productivities and mannitol yields from fructose are achieved in a process applying cell-recycle, continuous stirred tank reactor and/or circulation techniques with native LAB cells or with LAB cells with inactivated fructokinase gene(s). Mannitol is recovered in high yield and purity with the aid of evaporation and cooling crystallization.

Claims

exact text as granted — not AI-modified
1 . A process for the production of mannitol by bioconversion, comprising the steps of 
 bringing a high initial concentration of free, mannitol-producing lactic acid bacterial cells into contact with a low-nutrient medium supplemented with a substrate convertible into mannitol, and a cosubstrate, in a bioreactor system,    performing the bioconversion under conditions suitable for converting said substrate into mannitol,    separating the bacterial cells from the medium by filtration to obtain a cell-free solution,    recovering from the cell-free solution the mannitol produced, and    reusing the separated bacterial cells in the bioreactor system.    
     
     
         2 . The process according to  claim 1 , wherein the bacterial cells are native lactic acid bacterial cells.  
     
     
         3 . The process according to  claim 2 , wherein the bacterial cells are of the strain  Leuconostoc mesenteroides  ATCC-9135.  
     
     
         4 . The process according to  claim 1 , wherein the bacterial cells are fructokinase-inactivated lactic acid bacterial cells.  
     
     
         5 . The process according to  claim 4 , wherein the cells are of the strain  Leuconostoc pseudomesenteroides  BPT143 (DSM 14613).  
     
     
         6 . The process according to  claim 1 , wherein the substrate is fructose.  
     
     
         7 . The process according to  claim 1 , wherein the cosubstrate is glucose.  
     
     
         8 . The process according to  claim 1 , wherein the bioconversion is performed until at least 70%, preferably 90% or more of the said substrate has been consumed.  
     
     
         9 . The process according to  claim 1 , wherein an average volumetric mannitol productivity of at least 10 g/L/h is achieved.  
     
     
         10 . The process according to  claim 1 , wherein the bioconversion is performed as a batch process in a bioreactor system comprising a bioconversion reactor unit and a filtration unit.  
     
     
         11 . The process according to  claim 10 , comprising the steps of separating the bacterial cells from the medium after the bioconversion step, and reusing said cells in successive bioconversions.  
     
     
         12 . The process according to  claim 1 , wherein the bioconversion is performed as a circulation process in a bioreactor system comprising a bioconversion reactor unit, a filtration unit and a mixing reactor unit.  
     
     
         13 . The process according to  claim 12 , wherein the bacterial cells are circulated between the bioconversion reactor unit and the filtration unit.  
     
     
         14 . The process according to  claim 12  or  13 , comprising the steps of leading the cell-free solution obtained by the filtration into the mixing reactor, and transferring the solution from the mixing reactor back to the bioconversion reactor unit.  
     
     
         15 . The process according to any one of the  claims 12  to  14 , comprising emptying the mixing reactor after the bioconversion step, and re-filling it with said low-nutrient medium supplemented with said substrate and co-substrate, to run successive bio-conversions reusing said bacterial cells.  
     
     
         16 . The process according to  claim 1 , wherein the bioconversion is performed as a continuous process in a bioreactor system comprising a mixing tank, a feed tank, a bioconversion reactor unit, a filtration unit and a recovery tank.  
     
     
         17 . The process according to  claim 16 , wherein the bacterial cells are circulated between the bioconversion reactor unit and the filtration unit.  
     
     
         18 . The process according to  claim 16  or  17 , comprising the steps of feeding the bioconversion reactor unit continuously with said low-nutrient medium supplemented with said substrate and co-substrate, and removing the cell-free solution gained by filtration from the bioreactor to withhold a constant volume in the bioconversion reactor unit.  
     
     
         19 . The process according to any one of the  claims 10  to  18 , wherein the filtration unit is a tangential flow filtration unit.  
     
     
         20 . The process according to any one of the  claims 10  to  18 , wherein said bioconversion is run in series or in parallel.  
     
     
         21 . A bacterial strain of the genus Lactobacillus or Leuconostoc, in which the fructokinase enzyme(s) is/are inactivated.  
     
     
         22 . The bacterial strain according to  claim 21 , in which the fructokinase enzyme(s) is/are inactivated by random mutagenesis.  
     
     
         23 . The bacterial strain according to  claim 22 , which is  Leuconostoc pseudomesenteroides  BPT143 (DSM 14613).  
     
     
         24 . The bacterial strain according to  claim 21 , in which the fructokinase enzyme(s) is/are inactivated by directed mutagenesis.  
     
     
         25 . Use of a bacterial strain of the genus Lactobacillus or Leuconostoc, in which the fructokinase enzyme(s) is/are inactivated, for producing mannitol.

Join the waitlist — get patent alerts

Track US2004063183A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.